P

Inventor

HERBERTZ TORSTEN

US16 patents
⚠️ This page may combine multiple inventors who share the name “HERBERTZ TORSTEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FORMA THERAPEUTICS INC

14 patents
US10336722B2Jul 2, 2019

Tetrahydroquinoline compositions as BET bromodomain inhibitors

FORMA THERAPEUTICS INC22 citations93
US9422281B2Aug 23, 2016

Benzopiperazine compositions as BET bromodomain inhibitors

FORMA THERAPEUTICS INC25 citations93
US9388161B2Jul 12, 2016

Tetrahydroquinoline compositions as BET bromodomain inhibitors

FORMA THERAPEUTICS INC34 citations93
US11111229B2Sep 7, 2021

Tetrahydroquinoline compositions as BET bromodomain inhibitors

FORMA THERAPEUTICS INC4 citations83
US10611750B2Apr 7, 2020

Tetrahydroquinoline compositions as bet bromodomain inhibitors

FORMA THERAPEUTICS INC7 citations83
US10377769B2Aug 13, 2019

Benzopiperazine compositions as BET bromodomain inhibitors

FORMA THERAPEUTICS INC10 citations83
US10870648B2Dec 22, 2020

Inhibiting CREB binding protein (CBP)

FORMA THERAPEUTICS INC8 citations82
US10703764B2Jul 7, 2020

Benzopiperazine compositions as BET bromodomain inhibitors

FORMA THERAPEUTICS INC2 citations72
US11254674B2Feb 22, 2022

Inhibiting CREB binding protein (CBP)

FORMA THERAPEUTICS INC2 citations71
US11084831B1Aug 10, 2021

Benzopiperazine compositions as BET bromodomain inhibitors

FORMA THERAPEUTICS INC0 citations62
US12378242B2Aug 5, 2025

Inhibiting CREB binding protein (CBP)

FORMA THERAPEUTICS INC0 citations60
US11787803B2Oct 17, 2023

Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors

FORMA THERAPEUTICS INC0 citations60
US11292791B2Apr 5, 2022

Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors

FORMA THERAPEUTICS INC1 citations60
US12351577B2Jul 8, 2025

Inhibiting cyclic AMP-responsive element-binding protein (CREB)

FORMA THERAPEUTICS INC0 citations50

RYS DAVID J

2 patents